Suture-Mediated Closure For Both Femoral Arterial And Venous Access Sites
Perclose ProGlide™ Suture-Mediated Closure (SMC) System delivers a secure, non-masking percutaneous suture to the access site that promotes primary healing1 and has no reaccess restrictions.
This system has the broadest arterial and venous indication*; it can be utilized for 5-21F2 (Max. 26F OD4) arterial sheaths and 5-24F3 (Max. 29F OD4) venous sheaths. Abbott’s Perclose ProGlide™ SMC System also offers the following benefits:
Reduced time to hemostasis, ambulation and discharge6,10
Ability to challenge and confirm closure complete hemostasis on the table
Minimized inflammatory response7
Significantly lower blood transfusions, infections, mortality and shorter length of stay compared to surgical cutdown for large-bore arterial access8
Low major access site-related complications for large-bore venous access9
For EP labs, click hereto discover how Perclose ProGlide™ SMC System can improve EP lab workflow and enhance patient experience.
The Perclose ProGlide™ Suture-Mediated Closure System has the broadest indication for both femoral arterial and venous access.
For common femoral access sites
Max. OD
Artery
5–21F2
26F
Vein
5–24F3
29F
Max. OD 26F/0.340 inches/8.62 mm; Max. OD 29F/0.378 inches/9.59 mm. Tests performed by and data on file at Abbott.
Parallels the Surgical Gold Standard
Associated with significantly lower blood transfusions, infections, mortality, and shorter length of stay compared to surgical cutdown8
Secure repair with pre-tied polypropylene monofilament suture
Minimal intravascular footprint
Promotes Vessel Healing
Minimizes inflammatory response7
No re-access restrictions after using Abbott vascular closure devices
Gives In-Lab Confidence
Low access site-related complication,8,9 reduces time to hemostasis, ambulation, and discharge as compared to manual compression6,10
Suture repair can be challenged and confirmed on the table
Ability to maintain wire access
Suture-Based
Primary Intention Healing
Primary Wound Healing with Suture Repair
Clean Incision
Early Suture
"Hairline" Scar
References
*As compared to Angio-Seal‡, ExoSeal‡, FemoSeal‡, InClosure‡, MANTA‡, Mynx‡, PerQseal‡, Vascade‡, Velox CD‡, X-Seal‡. Data on file at Abbott.
Primary intention healing occurs where vessel wall edges are brought together, adjacent to each other. This can be achieved with suture, stitches, staples and clips.
For arterial sheath sizes greater than 8F, at least two devices and the pre-close technique are required.
For venous sheath sizes greater than 8F, at least one device and the pre-close technique are required.
Max. OD 26F/0.340 inches/8.62 mm; Max. OD 29F/0.378 inches/9.59 mm. Tests performed by and data on file at Abbott.
Time to hemostasis, ambulation and discharge applies to the arterial access.
Bhatt, Deepak L. et al. Successful “Pre-Closure” of 7Fr and 8Fr Femoral Arteriotomies With a 6Fr Suture-Based Device (The Multicenter Interventional Closer Registry). American Journal of Cardiology Vol 89. March 2002.
Mercandetti, Michael. Wound Healing and Repair. Medscape. WebMD, 02 April 2019. Web. January 15, 2020.
Perclose ProGlide™ Versus Surgical Closure Outcomes – Real World Evidence. Schneider, Darren B; Krajcer, Zvonimir; et al. LINC 2018.
The Use of the Perclose ProGlide™ Suture Mediated Closure (SMC) Device for Venous Access-Site Closure up to 24F Sheaths. Kar, Saibal; Hermiller, James; et al. CRT 2018.
Applies to arterial access.
MAT-2103417 v1.0
DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?
CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.
The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.
Do you want to continue?
Yes
The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.
